Glaucoma is the second most common cause of blindness worldwide, and the leading cause of bilateral, irreversible blindness. It is characterized by the relatively high intraocular pressure (IOP) as a result of impaired drainage of a fluid, known as aqueous humor, from the eye.
Key players in the North American ophthalmology glaucoma surgery device market include Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.), Lumenis Ltd. (Israel), Ellex Medical Lasers Ltd. (Australia), and IRIDEX Corporation (U.S.).
Browse through the TOC of the North American ophthalmology glaucoma surgery device market report to get an idea of the in-depth analysis provided. It also provides a glimpse of the segmentations in the market, and is supported by various tables and figures.
Currently, the approved treatments for glaucoma include a pharmaceutical drug, glaucoma laser therapies, and surgical procedures. It is estimated that by 2020, 11 million individuals will be blind due to glaucoma and around 10% of the people suffering from eye disorders will experience loss of vision in spite of proper treatment.
The North American ophthalmology glaucoma surgery devices market is driven by the growing incidences of ocular disorders, increased aging population, and rising prevalence of obesity and diabetes. However, lack of awareness among people regarding eye disorders and poor primary healthcare infrastructure are the major factors restraining the growth of ophthalmology glaucoma surgery devices market in this region.
The key players in the North American ophthalmology glaucoma surgery devices market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd.
(U.S.), Lumenis Ltd. (Israel), Ellex Medical Lasers Ltd. (Australia), and IRIDEX Corporation (U.S.).
This market is segmented and forecast on the basis of types and end-users. The types comprise of glaucoma drainage devices (gdd), glaucoma implants and stents, glaucoma lasers, and glaucoma systems while the end-users include private eye clinics, hospitals, and other end-users.
The North American ophthalmology glaucoma surgery devices market is further segmented and forecast on the basis of major countries, including the U.S., Canada, and Mexico. This report also includes the market share, value chain analyses, and market metrics, such as drivers, restraints, and upcoming opportunities in the market.
In addition, it presents a competitive landscape and company profiles of key market players.
No comments:
Post a Comment